Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study.

about

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study.

Item

http://www.wikidata.org/entity/Q37050295

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Phosphorylated-insulin growth ...... umors (GIST). A GEIS 19 study.

@en

Phosphorylated-insulin growth factor I receptor

@nl

type

Item

label

Phosphorylated-insulin growth ...... umors (GIST). A GEIS 19 study.

@en

Phosphorylated-insulin growth factor I receptor

@nl

prefLabel

Phosphorylated-insulin growth ...... umors (GIST). A GEIS 19 study.

@en

Phosphorylated-insulin growth factor I receptor

@nl

P1476

Phosphorylated-insulin growth ...... umors (GIST). A GEIS 19 study.

@en

P2093

Andrés Poveda

http://www.w3.org/2001/XMLSchema#string

Andrés Redondo

http://www.w3.org/2001/XMLSchema#string

Antonio López-Pousa

http://www.w3.org/2001/XMLSchema#string

Carlos Horndler

http://www.w3.org/2001/XMLSchema#string

Claudia Valverde

http://www.w3.org/2001/XMLSchema#string

Enrique de Alava

http://www.w3.org/2001/XMLSchema#string

Isabel Sevilla

http://www.w3.org/2001/XMLSchema#string

Javier Martinez-Trufero

http://www.w3.org/2001/XMLSchema#string

Joaquin Fra

http://www.w3.org/2001/XMLSchema#string

Jordi Rubió-Casadevall

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors.

Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells.

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors.

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance

Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.

Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.

P2888

s13569-016-0050-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13569-016-0050-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Javier Martín-Broto

Joan Maurel

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018123750

http://www.w3.org/2001/XMLSchema#string

P698

27358721

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

4926286

http://www.w3.org/2001/XMLSchema#string